Flash of hope: new Ultra-Fast radiation may tame skin cancer with fewer side effects
NCT ID NCT05724875
First seen Apr 05, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests a new type of radiation called FLASH, which delivers treatment in a fraction of a second, against standard radiotherapy for people with localized skin cancers (basal cell or squamous cell carcinoma). The goal is to see if FLASH can control the tumor just as well while causing fewer severe skin side effects. About 60 adults aged 60 and older who need radiation but cannot or choose not to have surgery will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Canton of Vaud, 1011, Switzerland
Conditions
Explore the condition pages connected to this study.